You can buy or sell EIDX and other stocks, options, ETFs, and crypto commission-free!
Eidos Therapeutics, Inc. engages in biotechnology and scientific developments. The company was founded by Graef Isabella and Alhamadsheh Mamoun and is headquartered in San Francisco, CA.
San Francisco, California
52 Week High
52 Week Low
Eidos Therapeutics (EIDX) Begins Phase 3 Study of AG10 in ATTR-CM with Registrational 12-month Endpoint
Eidos Therapeutics, Inc. (NASDAQ: EIDX) today announced the initiation and design of its pivotal global Phase 3 trial (ATTRibute-CM) of AG10 in patients with transthyretin (TTR) amyloid cardiomyopathy (ATTR-CM). The design of the ATTRibute-CM study, which incorporates feedback from FDA, includes two potentially registrational endpoints. In Part A, benefit in change from baseline in 6-minute walk distance (6MWD) will be evaluated at 12 months, potentially accelerating the time to registration. In Part B, red...
-$0.25 per share
Expected Today, After Hours